Cellosaurus cell line LD660 (CVCL

Cross-references
Cell line name	LD660
Accession	CVCL_EJ19
Resource Identification Initiative	To cite this cell line use: LD660 (RRID:CVCL_EJ19)
Sequence variations	Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9850064).
Disease	Bladder carcinoma (NCIt: C4912)
Species of origin	Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual	CVCL_EJ20 ! LD692
Sex of cell	Sex unspecified
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	PubMed=9850064 Markl I.D.C., Jones P.A. Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer. Cancer Res. 58:5348-5353(1998) PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350 Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D. Systematic review: characteristics and preclinical uses of bladder cancer cell lines. Bladder Cancer 4:169-183(2018)
Cell line databases/resources	cancercelllines; CVCL_EJ19
Encyclopedic resources	Wikidata; Q54902374
Polymorphism and mutation databases	Cosmic; 943738 IARC_TP53; 10279
Entry history
Entry creation	26-Sep-2016
Last entry update	19-Dec-2024
Version number	10